Orbimed Advisors Llc Buys 625,000 Shares of BlossomHill Therapeutics (NASDAQ:BLSM) Stock

Key Points

  • Orbimed Advisors LLC purchased 625,000 BlossomHill Therapeutics shares at $16.00 each, investing a total of $10 million.
  • The purchase increased Orbimed’s ownership by 29.91% to 2,714,279 shares, valued at approximately $43.4 million; the transaction was disclosed in an SEC filing.
  • BlossomHill shares opened at $16.24, compared with a 52-week range of $15.25 to $17.25. The clinical-stage biotechnology company is developing small-molecule cancer treatments, including its lead program BH-30643.

BlossomHill Therapeutics, Inc. (NASDAQ:BLSM - Get Free Report) Director Orbimed Advisors Llc bought 625,000 shares of the business's stock in a transaction on Monday, August 10th. The stock was purchased at an average cost of $16.00 per share, for a total transaction of $10,000,000.00. Following the transaction, the director owned 2,714,279 shares of the company's stock, valued at $43,428,464. This trade represents a 29.91% increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website.

BlossomHill Therapeutics Price Performance

NASDAQ:BLSM opened at $16.24 on Thursday. BlossomHill Therapeutics, Inc. has a 52 week low of $15.25 and a 52 week high of $17.25.

BlossomHill Therapeutics Company Profile

(Get Free Report)

BlossomHill Therapeutics Inc is a clinical-stage biopharmaceutical company applying an intentional, chemistry-based approach to design and develop small molecule medicines which address significant unmet medical needs in cancer treatment. The company's lead clinical programs include BH-30643. BlossomHill Therapeutics Inc is headquartered in San Diego, California.

Further Reading

This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].

Insider Buying or Selling at BlossomHill Therapeutics?
Sign-up to receive InsiderTrades.com's daily insider buying and selling report for BlossomHill Therapeutics and related companies.
From Our Partners
Free Insider Buying and Selling Newsletter
Enter your email address below to receive InsiderTrades.com's daily insider buying and selling report.
From Our Partners

Most Read This Month

Recent Articles